Safety and Efficacy Study of An Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple Myeloma

NCT05565807 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
84
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Zhejiang ACEA Pharmaceutical Co. Ltd.